-+ 0.00%
-+ 0.00%
-+ 0.00%

IMMUNEERING GRANTED ORPHAN DRUG DESIGNATION FOR IMM-1-104 BY FDA IN THE TREATMENT OF PANCREATIC CANCER

Reuters·10/15/2024 12:00:01

Please log in to view news